|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, July 20, 2017 ) According to Publisher, the Global Biodegradable Stents market is accounted for $0.47 billion in 2016 and is expected to reach $3.51 billion by 2022 growing at a CAGR of 39.8% during the forecast period 2016 to 2022. The prevailing usage of stents in treatment of artery disease is rapidly providing market growth. Patients demand for minimal invasive surgeries, growing geriatric population and technological advancements are some of the factors driving market. However, safety & regulatory issues and cost issues are some reasons behind the market lag.
For more information about this report: http://www.reportsweb.com/biodegradable-stents-global-market-outlook-2016-2022
Hospitals segment is expected to dominate the market, it is because of majority hospitals procuring medical products and consumables in bulk. Moreover, coronary artery disease is expected to dominate application segment on account of growing geriatric population and rising consequences of disease occurring. In geographical segment, North America is estimated to dominate the market due to high prevalence of cardiovascular diseases. In addition to that, Asia Pacific market is expected to grow at highest CAGR attributing to growing awareness about Bioabsorbable stents.
Some of the key players of the Biodegradable Stents market include Abbott Laboratories, Amaranth Medical, Inc., Arterial Remodeling Technologies SA, Arterius Limited, BIOTRONIK SE & Co. KG, Biotronik, Elixir Medical Corporation, Kyoto Medical Planning Co., Ltd., Meril Life Sciences, REVA Medical, Inc., SMT (Part of Sahajanand Group of Companies) , Tepha, Inc. and Xenogenics Corporation.
End-Users Covered:
-Cardiac Centers
-Hospitals
Applications covered:
-Coronary Artery Disease
-Peripheral Artery Disease
Materials covered:
-Metallic Stents
-Polymeric Stents
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001792557/sample
Drugs covered:
-Limus-Based Drugs
-Paclitaxel
Absorption Rates covered:
-Slow-Absorption Stents
-Fast-Absorption Stents
Regions Covered:
-North America-US-Canada-Mexico
-Europe-Germany-France-Italy-UK -Spain -Rest of Europe
-Asia Pacific-Japan-China-India-Australia-New Zealand-Rest of APAC
-Rest of the World-Middle East-Brazil-Argentina-South Africa-Egypt
Company Profiling
12.1 Abbott Laboratories
12.2 Amaranth Medical, Inc.
12.3 Arterial Remodeling Technologies SA
12.4 Arterius Limited
12.5 BIOTRONIK SE & Co. KG
12.6 Biotronik
12.7 Elixir Medical Corporation
12.8 Kyoto Medical Planning Co., Ltd.
12.9 Meril Life Sciences
12.10 REVA Medical, Inc.
12.11 SMT (Part of Sahajanand Group of Companies)
12.12 Tepha, Inc.
12.13 Xenogenics Corporation
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001792557/buying
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
